NCT06555796 · Interventional trial
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
Overall registry status Active not recruiting
Phase 1
Conditions High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer, High-risk Biochemical Recurrence, Non-metastatic Castration-sensitive Prostate Cancer, Prostate Cancer
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory